Shandong Xinhua Pharmaceutical Company Limited announced that at the annual general meeting, shareholders of the company approved the appointment of Mr. Lo Wah Wai as an independent non-executive director of the ninth session of the Board. The appointment has taken immediate effect. Mr. Lo’s term of directorship is concurrent with the ninth session of the Board until 22 December 2020. Mr. Chan Chung Kik, Lewis, who has agreed to hold office and continue to perform directorial duties and functions until the assumption of office by the new independent non-executive Director, has on the date of this announcement resigned from all offices and positions in the Group. Mr. Chan has confirmed that he resigned out of the need to devote more time to his other business commitments and has no disagreement with the Board or any matter which needs to be brought to the attention of the Shareholders. Following the shareholders’ approval of the appointment of Mr. Lo as an independent non-executive director, the Board has resolved to appoint Mr. Lo as the chairman of the Audit Committee and a member of the Nomination Committee and of the Remuneration and Examination Committee in view of the vacancies resulting from Mr. Chan’s resignation.